Literature DB >> 28935056

Epidemiology and Effects of Substance Use in Pregnancy.

Jocelynn L Cook1, Courtney R Green2, Sandra de la Ronde3, Colleen A Dell4, Lisa Graves5, Alice Ordean6, James Ruiter7, Megan Steeves8, Suzanne Wong9.   

Abstract

Substance use during pregnancy has important implications for health care providers and policymakers and can negatively affect a woman's health and the health of her children. Understanding trends, patterns of use, and outcomes are critical to developing prevention campaigns, building awareness, and providing effective care. This review critically examines the current literature on substance use in pregnancy and during the postpartum period in terms of epidemiology, risk factors, and implications. The risk factors for substance use in pregnancy, the challenges associated with reporting these cases, and the adverse effects of common substances on maternal and fetal health are discussed.
Copyright © 2017 Society of Obstetricians and Gynaecologists of Canada. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Substance use; cannabis; hallucinogens; opioids; pregnancy; stimulants

Mesh:

Year:  2017        PMID: 28935056     DOI: 10.1016/j.jogc.2017.07.005

Source DB:  PubMed          Journal:  J Obstet Gynaecol Can        ISSN: 1701-2163


  9 in total

Review 1.  Management of the Cardiovascular Complications of Substance Use Disorders During Pregnancy.

Authors:  P Kaitlyn Edelson; Sarah N Bernstein
Journal:  Curr Treat Options Cardiovasc Med       Date:  2019-11-22

2.  Association of adverse prenatal exposure burden with child psychopathology in the Adolescent Brain Cognitive Development (ABCD) Study.

Authors:  Joshua L Roffman; Eren D Sipahi; Kevin F Dowling; Dylan E Hughes; Casey E Hopkinson; Hang Lee; Hamdi Eryilmaz; Lee S Cohen; Jodi Gilman; Alysa E Doyle; Erin C Dunn
Journal:  PLoS One       Date:  2021-04-28       Impact factor: 3.240

3.  Substance Use and Utilization of Prenatal and Postpartum Care.

Authors:  Nichole Nidey; Laura R Kair; Christine Wilder; Tanya E Froehlich; Stephanie Weber; Alonzo Folger; Michael Marcotte; Karen Tabb; Katherine Bowers
Journal:  J Addict Med       Date:  2022 Jan-Feb 01       Impact factor: 3.702

4.  Pregnancy complications and premature cardiovascular events among 1.6 million California pregnancies.

Authors:  Rima Arnaout; Gregory Nah; Greg Marcus; Zian Tseng; Elyse Foster; Ian S Harris; Punag Divanji; Liviu Klein; Juan Gonzalez; Nisha Parikh
Journal:  Open Heart       Date:  2019-02-27

5.  Overall Maternal Morbidity during Pregnancy Identified with the WHO-WOICE Instrument.

Authors:  Stephanie Pabon; Mary A Parpinelli; Martha B Narvaez; Charles M'poca Charles; Jose P Guida; Maria F Escobar; Jose G Cecatti; Maria L Costa
Journal:  Biomed Res Int       Date:  2020-07-17       Impact factor: 3.411

6.  Adverse childhood experiences are associated with illicit drug use among pregnant women with middle to high socioeconomic status: findings from the All Our Families Cohort.

Authors:  Cheryl L Currie; Suzanne C Tough
Journal:  BMC Pregnancy Childbirth       Date:  2021-02-13       Impact factor: 3.007

7.  Prevalence and Associated Factors of Common Mental Disorders Among Pregnant Mothers in Rural Eastern Ethiopia.

Authors:  Dawit Tamiru; Tadesse Misgana; Mandaras Tariku; Dejene Tesfaye; Daniel Alemu; Adisu Birhanu Weldesenbet; Berhe Gebremichael; Merga Dheresa
Journal:  Front Psychiatry       Date:  2022-03-28       Impact factor: 4.157

8.  Perinatal Behavioral Health, the COVID-19 Pandemic, and a Social Determinants of Health Framework.

Authors:  Sharon L Ruyak; Katie T Kivlighan
Journal:  J Obstet Gynecol Neonatal Nurs       Date:  2021-06-16

9.  Community networks of services for pregnant and parenting women with problematic substance use.

Authors:  Karen Urbanoski; Chantele Joordens; Gillian Kolla; Karen Milligan
Journal:  PLoS One       Date:  2018-11-19       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.